In 2004, Loren Israelsen and I wrote an editorial for NBJ titled “DSHEA, 10 Years Later: Now What?” We tried to address industry challenges in the aftermath of ephedra, and strategies to protect our core piece of legislation on its 10th anniversary. Some of the strategies I recommended then are still appropriate today, and require resolving signature issues that we still face, including 1) the “unregulated industry” issue, 2
All access premium subscription
This content requires a subscription to Nutrition Business Journal.
As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.
Email [email protected] for more information about subscribing.